DE68906193T2 - Hypersphyxia verursachende zusammensetzung. - Google Patents

Hypersphyxia verursachende zusammensetzung.

Info

Publication number
DE68906193T2
DE68906193T2 DE1989606193 DE68906193T DE68906193T2 DE 68906193 T2 DE68906193 T2 DE 68906193T2 DE 1989606193 DE1989606193 DE 1989606193 DE 68906193 T DE68906193 T DE 68906193T DE 68906193 T2 DE68906193 T2 DE 68906193T2
Authority
DE
Germany
Prior art keywords
keto
ester
group
dihydro
pge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1989606193
Other languages
German (de)
English (en)
Other versions
DE68906193D1 (de
Inventor
Tomio Oda
Ryuji Ueno
Ryuzo Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12530388A external-priority patent/JPH089543B2/ja
Priority claimed from JP18228188A external-priority patent/JP2760514B2/ja
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of DE68906193D1 publication Critical patent/DE68906193D1/de
Application granted granted Critical
Publication of DE68906193T2 publication Critical patent/DE68906193T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE1989606193 1988-05-23 1989-05-22 Hypersphyxia verursachende zusammensetzung. Expired - Fee Related DE68906193T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12530388A JPH089543B2 (ja) 1988-05-23 1988-05-23 呼吸促進剤
JP18228188A JP2760514B2 (ja) 1988-07-20 1988-07-20 循環機能昂進剤

Publications (2)

Publication Number Publication Date
DE68906193D1 DE68906193D1 (de) 1993-06-03
DE68906193T2 true DE68906193T2 (de) 1993-08-05

Family

ID=26461770

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1989606193 Expired - Fee Related DE68906193T2 (de) 1988-05-23 1989-05-22 Hypersphyxia verursachende zusammensetzung.

Country Status (4)

Country Link
EP (1) EP0343904B1 (https=)
DE (1) DE68906193T2 (https=)
ES (1) ES2055051T3 (https=)
GR (1) GR3007748T3 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410652B1 (en) * 1989-07-27 1995-05-17 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of 15-keto-prostanoic acid derivatives in the manufacture of a medicament for improvement of excretion of potassium ion
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
ATE121624T1 (de) * 1989-08-09 1995-05-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von prostansäurederivaten zur herstellung von arzneimitteln zur verbesserung der ausscheidung von nichtprotein in die därme.
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
TW224942B (https=) * 1990-04-04 1994-06-11 Adka Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
AU739343B2 (en) 1997-11-28 2001-10-11 Sucampo Ag Endothelin antagonist

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins

Also Published As

Publication number Publication date
ES2055051T3 (es) 1994-08-16
DE68906193D1 (de) 1993-06-03
EP0343904B1 (en) 1993-04-28
EP0343904A1 (en) 1989-11-29
GR3007748T3 (https=) 1993-08-31

Similar Documents

Publication Publication Date Title
DE3850676T2 (de) Hypotensive okulare Mittel.
DE3608088C2 (de) Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE68905241T2 (de) Tracheobronchodilatator.
DE68928551T2 (de) Oculare hypotensive Mittel
DE68906193T2 (de) Hypersphyxia verursachende zusammensetzung.
DE3873007T2 (de) Kathartica.
DE2819447A1 (de) Prostaglandin-analoge enthaltende praeparate
KR920007570B1 (ko) 체온 상승제
DE69105349T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
DE68908950T2 (de) Anwendung von 15-Keto-prostaglandin-E- oder F-Verbindungen für uterine Kontraktionen.
DE69024744T2 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
AT396687B (de) Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
DE69210286T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination
DE68918726T2 (de) Isocarbacyclinderivate enthaltende Antidiabetika.
DE69123892T2 (de) Behandlung von Katarakt mit prostacyclinverbindungen
US5362751A (en) Tracheobronchodilator using 16-substituted PGEs
US5169863A (en) Hypersphyxia-causing methods
DE4008925A1 (de) 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel
JP2760514B2 (ja) 循環機能昂進剤
DE69006964T2 (de) Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.
JPH04187637A (ja) 記憶改善剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH

8339 Ceased/non-payment of the annual fee